Amikacin-heparin lock for prevention of catheter-related bloodstream infection in neonates with extended umbilical venous catheters use: A randomized controlled trial

Journal of Neonatal-Perinatal Medicine

Volumn 3, Issue 1, 2010, Pages 33-41

  Seliem, Wael ^a,b   Abdel Hady, Hesham ^a   El Nady, Ghada ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

Author keywords

Amikacin; Antibiotic lock; Catheter related bloodstream infection; Neonate

Indexed keywords

AMIKACIN; HEPARIN; SODIUM CHLORIDE;

ANTIBIOTIC LOCK; ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; CATHETER INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INDWELLING CATHETER; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UMBILICAL VEIN CATHETERIZATION; VEIN CATHETERIZATION;

EID: 77953384551     PISSN: 19345798     EISSN: 18784429     Source Type: Journal    
DOI: 10.3233/NPM-2010-0090     Document Type: Article

References (31)

1. D.B. Loisel, M.M. Smith, M.G. MacDonald and G.R. Martin, Intravenous access in newborn infants: impact of extended umbilical venous catheter use on requirement for peripheral venous lines, J Perinatol 16 (1996), 461-466.
2. D.W. Cartwright, Central venous lines in neonates: a study of 2186 catheters, Arch Dis Child Fetal Neonatal 89 (2004), 504-508.
3. S.E. Perlman, L. Saiman and E.L. Larson, Risk factors for late onset health care - associated bloodstream infections in patients in neonatal intensive care units, Am J Infect Control 35 (2007), 177-182.
4. J.R. Edwards, K.D. Peterson, M.L. Andrus et al., National Healthcare Safety Network (NHSN) report, data summary for 2006, Am J Infect Control 35 (2006), 290-301.
5. L.M. Mahieu, J.J. De Dooy, A.O. De Muynck et al., Microbiology and risk factors for catheter exit site and hub colonization in neonatal intensive care unit patients, Infect Control Hosp Epidemiol 22 (2001), 357-362.
6. US Department of Health and Human Services, Centers for Disease Control and Prevention, Guideline for prevention of intravascular device-related infection, MMWR Recomm Rep 51 (2002), 1-36.
7. H. Aly, V. Herson, A. Duncan et al., Is bloodstream infection preventable among premature infants? A tale of two cities, Pediatrics 115 (2005), 1513-1518.
8. G.D. Inglis and M.W. Davies, Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous catheters, Cochrane Database Syst Rev 19 (2005), CD005251.
9. J. Carratal̀a, The antibiotic-lock technique for therapy of "highly needed" infected catheters, Clin Microbiol Infection 8 (2002), 282-289.
10. J.S. Garland, C.P. Alex, K.J. Henrickson et al., A vancomycinheparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: A prospective, randomized trial, Pediatrics 116 (2005), e198-e205.
11. L. Filippi, M. Pezzati, S. Di Amario, C. Poggi and P. Pecile, Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial, Pediatr Crit Care Med 8 (2007), 556-562.
12. G. Bertini, F. Ceciarini, A. Benuzzi, S. Elia, C. Dani and F.F. Rubaltelli, A Fusidic-Heparin Lock Solution and Silver Coated Central Venous Catheters in Preventing Staphylococcus Catheter-Related Bloodstream Infections in VLBW Infants, Pediatric Academic Societies' Annual Meeting (2008), E-PAS2008:633235.1.
13. A. Ahmed, M. Chowdhury,M. Hoque and G. Darmstadt, Clinical and bacteriological profile of neonatal septicaemia in a tertiary level pediatric hospital in Bangladesh, Indian Pediatrics 39 (2002), 1034-1039.
14. G. Kumhar, V. Ramachandran and P. Gupta, Bacteriological analysis of blood culture isolates from neonates in a tertiary care hospital in India, J Health Pop Nutr 20 (2002), 343-347.
15. G. Darmstadt, N. Badrawi, P. Law et al., Topical therapy with sunflower seed oil prevents nosocomial infections and mortality in premature babies in Egypt: a randomized, controlled clinical trial, Pediatr Infect Dis J 23 (2004), 719-725.
16. H. Abdel-Hady, S. Hawas, M. El-Daker and R. El-Kady, Extended spectrum ß-Lactamase producing klebsiella pneumoniae in neonatal intensive care unit, J Perinatol 28 (2008), 685-690.
17. N. Fernandez-Hidalgo, B. Almirante, R. Calleja, I. Ruiz, A.M. Planes, D. Rodriguez, C. Pigrau et al., Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study, J Antimicrob Chemother 57 (2006), 1172-1180.
18. K.J. Henrickson, R.A. Axtell, S.M. Hoover et al., Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial, J Clin Oncol 18 (2000), 1269
19. I. Raad, W. Costerton, U. Sabharwal, M. Sacilowski, E. Anaissie and G.P. Bodey, Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement, J Infect Dis 168 (1993), 400-407.
20. B. Messing, S. Peitra-Cohen, A. Debure et al., Antibiotic-lock technique: A new approach to optimal therapy for catheterrelated sepsis in home-parenteral nutrition patients, J Parenter Enteral Nutr 12 (1988), 185-189.
21. A. Lodha, A.D. Furlan, H. Whyte and M. Moore, Prophylactic antibiotics in the prevention of catheter-associated bloodstream bacterial infection in preterm neonates: a systematic review, J Perinatol 28 (2008), 526-533.
22. Centers for Disease Control, National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999, Am J Infect Control 27 (1999), 520-532.
23. J. Curtin, M. Cormican, G. Fleming, J.Keelehan and E. Colleran, Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheterrelated biofilm infections, Antimicrob Agents Chemother 47 (2003), 3145-3148.
24. J.F. Klein and F. Shahrivar, Use of percutaneous silastic central venous catheters in neonates and the management of infectious complications, Am J Perinatol 9 (1992), 261-264.
25. V. Hruszkewycz, P.C. Holtrop, D.G. Batton et al., Complications associated with central venous catheters inserted in critically ill neonates, Infect Control Hosp Epidemiol 12 (1991), 544-548.
26. M.B. Salzman, H.D. Isenberg, J.F. Shapiro et al., A prospective study of the catheter hub as the portal of entry for microor ganisms causing catheter-related sepsis in neonates, J Infect Dis 167 (1993), 487-490.
27. M. Butler-O'Hara, C.J. Buzzard, L. Reubens, M.P. McDermott, W. DiGrazio and C.T. D'Angio, A Randomized Trial Comparing Long-term and Short-term Use of Umbilical Venous Catheters in Premature Infants With Birth Weights of Less Than 1251 Grams, Pediatr 118 (2006), e25-e35.
28. J.H. Kim, Y.S. Lee, S.H. Kim, S.K. Lee, M.K. Lim and H.S. Kim, Does umbilical vein catheter lead to portal venous thrombosis? Prospective US evaluation in 100 neonates, Radiol 219 (2001), 645-650.
29. M. Roy, S. Turner-Gomes, G. Gill, C. Way, J. Mernagh and B. Schmidt, Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters, J Pediatr 140 (2002), 131-134.
30. A.G. Randolph, D.J. Cook, C.A. Gonzales and M. Andrew, Benefit of heparin in central venous and pulmonary artery catheters: a metaanalysis of randomized controlled trials, Chest 113 (1998), 165-171.
31. A.K. Saxena, B.R. Panhotra and M. Naguib, Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock, Pharmacotherapy 22 (2002), 105-108.